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ABSTRACT 
PURPOSE:  
 The purpose of this study is assessment of blood loss in orthognathic 
surgery using nitroglycerine induced hypotensive anaesthesia and comparison 
of pre and postoperative haemoglobin, haematocrit and means arterial 
pressure.  
MATERIALS AND METHOD: 
 10 young orthognathic patients were operated under hypotensive 
anaesthesia included in this study. Operations were Anterior maxillary 
osteotomies (n=6), Lefort I osteotomy (n=1), BSSRO (n=3), Sub apical 
osteotomy (n=1), Genioplasty (n=3). Pre and Post operative Haemogram, intra 
operative blood loss, duration of surgery were the studied parameters. 
Statistical analysis was performed using SPSS version 19. 
RESULTS: 
 None of the patient required blood transfusion. Mean blood loss was 
174.19ml with a range of 77.60 ml to maximum of 283 ml. Mean duration was 
174 min with minimum of 75 min and maximum of 290 min. Mean preop Hb 
level  was 12.14 gm%/dl and the mean postop Hb level was 10.14 gm%/dl. 
Mean preop Haemotocrit was 40.50% and postop Haemotocrit was 30.18%. 
The mean arterial pressure was 72.86 mmHg with a minimum of 63.30 mmHg 
and maximum of 78.60 mmHg. 
CONCLUSION: 
 Blood transfusion in orthognathic surgery could be prevented by 
induction of Nitroglycerine as hypotensive anaesthetic agent and reduces the 
length of surgery by improving the quality of surgical field. 
KEYWORDS: 
 Nitroglycerine, induced hypotensive anaesthesia, blood loss, 
haemoglobin, haematocrit, Mean arterial pressure, Orthognathic surgery.  
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INTRODUCTION 
 Orthognathic surgery is well established for the correction of 
dentofacial deformities in terms of its outcome and safety, and bimaxillary 
osteotomies are frequently necessary to achieve an acceptable result. Due to 
the complex vascularity of the orofacial region, significant bleeding not 
readily controllable by conventional surgical techniques, especially when it 
involves intra bony capillaries are encountered resulting in the need for blood 
transfusion. Homologous blood transfusion is associated with a number of 
risks including transmission of bacterial, viral or protozoal infections and 
alloimmunization, and various strategies are available to minimize the likely 
need for such transfusion. 
            The orthognathic surgeries are Bilateral sagittal split ramus osteotomy, 
Subapical osteotomy, Genioplasty in Mandible. Lefort I osteotomy, Anterior 
maxillary osteotomy in Maxilla for the correction of various jaw deformities. 
However single-jaw and Bi-Jaw Procedure is performed separately in many 
patients.   
 Several authors like J.E Moening et al,
34
 D.S. Precious et al,
39
 Robert 
M. Dolman et al,
41
 Nabil Samman et al
35
 have done studies on effect of 
induced hypotensive anaesthesia in orthognathic surgery.  
            Deliberate hypotensive anaesthesia was first introduced by Gardner
24
 
who used arteriotomy to reduce arterial blood pressure during surgery in1946. 
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Since then, various techniques for inducing hypotension during surgery have 
been used in orthopaedic and neurosurgical procedures, and the technique was 
first used in oral and maxillofacial surgery by SCHABERG et al.
44 
in 1976. 
Hypotensive anaesthesia has shown to reduce intraoperative blood loss in 
orthognathic surgeries. 
           Deliberate, controlled, hypotensive anaesthesia has been used during 
general surgical procedures in an attempt to reduce intraoperative 
haemorrhage and the resultant need for transfusion. In addition, it is claimed to 
improve the quality of the surgical field and reduce operative time. 
            Progress in anaesthesia has allowed more time for a surgeon to be 
fastidious about haemostasis, and new surgical techniques have improved the 
surgeon’s ability to control bleeding. The controlled induction and 
maintenance of intraoperative controlled moderate hypotension (CMH) has 
become an important part of a major maxillofacial operation involving 
osteotomy of the mid face (Dolman et all, 2000).
41
 
 An arterial blood pressure  30% below a patient’s usual  MAP, with a  
minimum arterial pressure of 50 mmHg in American society of 
anaesthesiologists (ASA) I patients and a MAP not less than 80 mmHg in the 
elderly, is suggested as being clinically acceptable, as this does not impair 
perfusion of brain, heart, kidney and liver. Various pharmacological agents 
have been used for inducing hypotension during orthognathic surgery. 
Duration of CMH carries importance because prolonged hypoperfusion is not 
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innocent and decrease of MAP below 70 mmHg might increase intraoperative 
blood loss due to vasodilatation. 
            Controlled hypotension rarely results in damage, however because 
organ blood flow is normally well maintained. Mortality due to controlled 
hypotension and consequent ischaemic organ failure was 0.02 – 0.06%.  
Current data indicate that MAP between 60 and 75 mmHg is safe for young 
healthy patients. 
            The two major benefits of CMH are reduction of blood loss and 
improvement in visibility of the surgical field. Reduction of blood loss 
eliminates the need for homologous blood transfusion, which has a potential 
risk of transmitting serious infections and causing haemolytic reactions. 
Estimated blood loss in orthognathic surgery with hypotensive anaesthesia has 
been reduced to 41 %.   
            CMH is contraindicated in presence of severe cardiac and respiratory 
diseases, our orthognathic patients are ASAPS I who are fit, young and 
healthy adults. 
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AIM AND OBJECTIVE 
 The purpose of this study is assessment of blood loss in orthognathic 
surgery using Nitroglycerine induced hypotensive anaesthesia and comparison 
of pre & post-operative Haematocrit, haemoglobin, MAP and RBC. 
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REVIEW OF LITERATURE 
 Control of haemorrhage and concept of hypotension began as early as 
1917 by Harvey cushing and in 1946 James gardener adopted this concept into 
general anaesthesia. 
 Deliberate induction of hypotension in a controlled and safe manner 
with the mean arterial pressure maintained at 55-65 mmHg has been used in 
orthopaedic, pelvic, head and neck surgery and is valuable and effective in 
ENT, ophthalmic and neurosurgery. 
 Blood flow and organ perfusion is maintained by auto regulatory vaso-
dilatation and hence this is a safe method in the range MAP of 60-70 mmHg. 
 Intra operative monitoring can be done by both Invasive and Non-
invasive methods. In Non-invasive method of monitoring ECG, blood 
pressure, HR, PO2 can be done using pulse oximeter. In invasive method EEG, 
Canography, HR, blood pressure, PO2, PCO2, body temperature can be 
calculated. 
 Invasive monitoring of blood pressure is more reliable and a sensitive 
indicator of cerebral perfusion, especially with the use of rapidly acting 
hypotensive agents like sodium nitroprusside, Trimetaphan are used or with 
wide fluctuation of blood pressure expected. 
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 Capnography can be used to measure sudden changes in end expiratory 
PCO2. It is used to avoid hyperventilation as decrease in PCO2 decreases 
cerebral blood flow during hypotension. 
 Electroenchaphalography (EEG) is required to detect cortical 
hypoperfusion. Electrical activity becomes abnormal in cerebral blood flow at 
20ml/minute. 
Hypotensive drugs – Anaesthetic categories. 
1. Ganglion blocking agents – Pentamethonium, Trimetaphan 
2. Volatile anaesthetic agents – Isoflurane, Enflurane 
3. Direct acting vasodilators – Nitroglycerine, Sodium nitroprusside, 
Calcium channel blockers, Beta-blockers, purine derivatives, 
Prostaglandin E. 
EFFECTS OF HYPOTENSION ON ORGAN PERFUSION: 
Central Nervous System: 
 Perfusion Pressure = Arterial input pressure -  Venous out flow                               
                                      Pressure (MAP-ICP) 
 Minimum of 40 mmHg of perfusion pressure should be maintained 
essentially. 
 Auto regulation is active till MAP 50-55 mmHg in normothermic 
patients. 
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Heart: 
 Dead space and PaCo2 increases when cardiac output is decreased. 
 Nitroglycerine and Sodium Nitroprusside decreases Oxygenation. 
 Controlled ventilation is preferred since it causes changes in 
oxygenation and eliminates CO2. 
Kidneys: 
 Renal blood flow accounts 20-25% of cardiac output. 
 Auto regulation is efficient. 
  Recovery of urine production is efficient in Normovolemic patients. 
 No need of strict monitoring in short surgeries is required. 
Splanchnic circulation: 
 During hypotension there is a change in liver perfusion because 
Pressure-flow auto regulation in absent in portal venous circulation. 
 Auto regulation in intestine is less effective. 
 It’s very difficult to do clinical monitoring of splanchnic circulation. 
Eye: 
 With the decrease in arterial BP the intraocular pressure decreases. 
 Blindness may rarely occur due to blurring of vision. 
Skin and Muscle: 
 Deliberate hypotension does not affects skin. 
 When compared with nitroglycerine, sodium nitroprusside decreases 
Tissue oxygenation. 
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 Bleeding during surgery depends on number of vessels cut, rate of flow 
from cut vessel and effectiveness of haemostasis. Rate of flow is the only 
controllable variable. It also depends on size of vessel and intraluminal 
pressure. Cardiac output or decreasing venous return can be able to control 
intraluminal pressure. The later is not preferred, as it will decrease tissue 
perfusion. Hence reducing venous return is the best option.  The principle of 
hypotensive anaesthesia is thus to induce low pressure, vasodilated 
circulation. 
            Deliberate induction of hypotension during anaesthesia is an attempt to 
produce a controlled and safe reduction in intravascular pressure in 
hypotensive anaesthesia. The MAP is maintained at 60-70 mmHg during the 
surgery. The principle of controlled hypotension is to induce a low 
pressure, vasodilated circulation. 
 FUTURE OF CONTROLLED HYPOTENSIVE ANAESTHESIA: 
  Guyuron et al
21
 evaluated and proved that Efficacy of hypotensive 
anaesthesia along with coagulant Desmopressin. No significant side effects of 
Desmopressin were reported. 
            In total hip surgeries Ekback et al
11
 did a double-blinded study 
reporting 35% decrease in bleeding on administration of antifibrinolytic agent 
Tranxemic acid preoperatively. 
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          A    Goran et al
18
 showed that blood loss during orthognathic surgeries 
under hypotensive anaesthesia (MAP<65mm Hg) could be significantly 
reduced when a combination of tranexamic acid and desmopressin is added. 
The mean blood loss was 740 ml in control group whereas it was 400 ml in 
treatment group. 
              W. James Gardner 1946
24
 introduced arteriotomy. In this procedure 
blood was withdrawn from the patient preoperatively via the arterial route and 
then replaced in part by the same manner at the end of operation. This 
reduction in total circulating blood volume leads to lowering of blood pressure 
and peripheral vasoconstriction. Hence, decreased blood loss perioperatively. 
           Mc Neill TW et al 1974
36
 et al did a retrospective study, comparing 
normotensive (22 patients) and hypotensive (44 patients) anaesthesia for spine 
fusion. The use of hypotensive anaesthesia was found to decrease the need for 
blood replacement and total blood loss by an average of 40% and to reduce the 
average operating time by more than 30 min. No complications attributable to 
anaesthetic technique occurred. 
 Schaberg et al 1976
44
 has evaluated effect of sodium nitroprusside 
infusion supplemented with halothane in oro-facial corrective surgery. Various 
physiological parameters were measured pre operatively, intra operatively and 
post operatively to evaluate patient response to this anaesthetic method. The 
mean arterial pressure was reduced from 89.94 ±2.13 to 72.79 ± 1.63 mg 
under the influence of sodium nitroprusside. It is concluded from an extensive 
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review of the literature that the most vulnerable period for serious 
complication is in the immediate postoperative period. No significant 
complications were observed in this study. 
          Kerr AR
 
1977
26
 produced a blood-free field for middle ear surgery 
performed with the operating microscope; the arterial systolic pressure was 
reduced to less than 50 mm Hg in 700 patients by means of thiopentone- 
halothane-nitrous oxide in oxygen anaesthesia together with pentolinium 
tartrate. In 84% the results were excellent, in 12% moderately good and they 
were poor in 4%. There were more unsatisfactory results in males (22.8%) 
than in females (11.4%). In spite of the arterial pressure being reduced to low 
values in main instances, there was no mortality or morbidity, which could be 
ascribed to the technique. 
         Thompson GE et al 1978
49
 attempted to determine effect of 
hypotensive anaesthesia on postoperative brain, liver, kidney and myocardium 
following total hip arthroplasty. MAP was decreased to 50 mmHg using high 
concentration of halothane or sodium nitroprusside. In the control group, MAP 
was maintained with 20% base line. Intraoperative blood loss decreased from 
1,183 ±172ml normotensive to 406±102ml and 326 ± 41ml in halothane and 
nitroprusside hypotensive group respectively. Neither method affected the 
cerebral, hepatic or renal and myocardial function. There was no morbidity. 
Operating time was significantly reduced. Decreased blood loss lead to 
decrease in number of blood transfusions needed. 
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            Gallagher DM et al 1979
16
 reported that achieving satisfactory 
haemostasis during orthognathic surgery might be difficult because of the 
extensive vascularity of facial structures. Hypotensive anaesthetic techniques 
provide clear operative field by altering regional tissue perfusion through the 
use of systemic vasodilators, ganglionic blocking agents and positioning of the 
patient. Though monitoring during surgery, careful selection of patients, and 
close communication between the surgery and anaesthesiologist permit safe 
anaesthesia can decrease operating time, and usually obviate the need for 
transfusion. 
         Vandesteene et al 1980
52
 have used sodium nitroprusside 0.01% 
solution to induce hypotensive state. Mean dose to maintain a mean blood 
pressure at about 50 mmHg was 1.37mcg/kg/min.  The patients were operated 
for cerebral aneurysm or angioma. Adjuvant drugs and methods to reduce 
intracranial pressure such as dexamethasone, mannitol and cerebrospinal fluid 
substraction were used. 
        Sivarajan M et al 1980
46
 emphasized that blood pressure and not cardiac 
output, determines blood loss during induced hypotension. Cardiac output 
characteristically decreases during trimethaphan Infusion but is well 
maintained or increased during sodium nitroprusside infusion. They postulated 
that at similar levels of mean arterial pressure, sodium nitroprusside might be 
associated with greater blood loss than trimethaphan due to the increase in 
cardiac output. They studied 20 young healthy patients scheduled for bilateral 
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sagittal osteotomies of the mandible. Ten subjects received trimethaphan and 
10 subjects received sodium nitroprusside. Using halothane (0.5 – 1%) & 
(60%) for maintenance of anaesthesia, trimethaphan or sodium nitroprusside 
was infused to maintain MAP between 55-60 mmHg; cardiac output was 
measured in five subjects in each group. Heart rate and cardiac output 
increased significantly and total peripheral resistance decreased significantly, 
during sodium nitroprusside infusion when compared to trimethaphan duration 
of hypotension or in blood loss. They include that operative blood loss during 
induced hypotension is determined by mean arterial pressure not cardiac 
output. 
 Chan W et al 1980
6
 compared the blood loss, quality of operative 
field and he length of surgery in one type of orthognathic surgery – anterior 
maxillary osteotomy in normotensive and hypotensive anaesthesia. They 
found that by dropping a patients operative mean blood pressure below his 
mean blood pressure by 20% or more, the quality of the surgical field can be 
significantly improved (27%) and loss of blood can be decreased (41%). 
            Ward CF et al 1980
54
 have described the effect of blood pressure 
reduction on organ perfusion, when deliberate reduction of blood pressure to 
reduce intraoperative blood loss was used. 
            Bergman S et al RF 1982
3
 hypotensive anaesthesia is currently being 
used in oral and maxillofacial surgery to reduce blood loss and provide a 
relatively bloodless surgical field. Radioactively labelled microspheres were 
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used to determine and compare the haemodynamic effects of sodium 
nitroprusside (SNP), nitroglycerin (NTG) and deep enflurane anaesthesia on 
oral tissues during controlled hypotension when compared with controls. 
Sodium nitroprusside and NTG produced significant reductions in blood flow 
to the maxilla, mandible and tongue, while deep enflurane anaesthesia did not. 
In the masseter and suprahyoid muscles, increases in tissue blood flow were 
found with SNP and enflurane. Nitroglycerine produced no significant change 
in blood flow in the masseter and suprahyoid. These results demonstrate that 
in spite of a similar cardiac index with all agents tested, local oral blood flow 
varied significantly with the different agents tested. These differences in tissue 
blood flow suggest that SNP and NTG may be preferable to deep enflurane 
anaesthesia for maxillary osteotomies to achieve greater flow reduction and 
diminish blood flow.   
        Fahmy S 1983
14
 substituted enflurane for halothane to induce 
controlled hypotension, along with B-blockers and sympathetic ganglion 
blockers, in two groups. They constituted 1) Major maxillofacial surgery                   
2) Major neurosurgery. All patients were carefully monitored during 
anaesthesia and for24 hours post operatively. Good operative conditions were 
produced and no ill effects of controlled hypotension were detected in any of 
the patients. 
Beierholm WE et al 1983
2
 studied the haemodynamic effects of 
sodium nitroprusside in 6 patients undergoing surgery for intracranial 
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aneurysm under controlled hypotension in endotracheal anaesthesia with 
halothane – nitrous oxide during hypocapnia mean arterial pressure was 
reduced with SNP from mean 12.25 Kpa to mean 8.29 Kpa [32%]. There were 
concomitant statistically significant heart rate, central venous pressure and 
pulmonary vascular resistance did not change significantly. After the infusion 
of SNP was discontinued all parameters except cardiac index and heart rate, 
return to values not significantly different from the control values. The 
hypotension induced by SNP resulted from reductions in cardiac index and 
systemic vascular resistance. The reduction in cardiac index did not reach a 
critical level in any of the patients. 
 Lam AM et al 1983
28
 Deliberate hypotension induced with isoflurane 
in 13 patients, undergoing craniotomy for clipping of aneurysms. 
Cardiovascular functions and gas exchange were monitored before, during and 
after hypotension. In all cases, the desired level of hypotension [40+/- 
1.0(SEM) mmHg] was achieved readily with prompt onset (5.7+/- 1.0 min) 
and recovery (6.3+/- 0.7 min). Cardiac output during hypotension (4.6+/- 0.3 
L /min) was not significantly different from the control normotensive values 
(4.80 +/- 0.3 L / min). Gas tensions during hypotension and during 
normotension were PaO2 116+/- 6 and 111+/- 8 mmHg; respectively. No 
complication could be attribuited to the use of isoflurane. We conclude that 
isoflurane can be employed safely and effectively as a hypotensive agent in 
neurosurgery. 
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 Golia JK et al 1985
17 
has used nitroglycerine for controlled 
hypotension in orthognathic surgeries. Nitroglycerine (NTG) was chosen 
because of its beneficial cardiovascular effects and its lack of toxicity as 
compared with sodium nitroprusside 9 patients undergoing either maxillary or 
maxillary / mandibular osteotomies were anaesthetized with halothane, N2O, 
O2 and supplementary dose of muscle relaxants and narcotic. NTG was used 
to lower mean arterial pressure during periods of potential increased blood 
loss. Estimated blood loss was 439+/- 1.19ml.  Haemoglobin and haematocrit 
fell slightly from 13.8+/-1.74gm/dl and 41.2+/-5.11%   to 12.04 +/- 1.8gm/dl 
and 35.6+/- 4.9%. Alteration of the pulmonary hypoxic vasoconstriction reflex 
was also seen as was evidenced by a decrease in PaO2 after NTG 
administration. It was concluded that NTG is a safe and efficacious agent for 
controlled circulation during maxillary osteotomy surgery. 
 Guggiari M et al in 1985
20 
the cardiovascular effects of nitroglycerine 
(NTG) were studied in 30 patients requiring controlled hypotension for 
intracranial aneurysm surgery. In patients “resistant” to NTG (n=9), sodium 
nitroprusside (SNP) was used to supplement the NTG. With NTG alone at a 
total dose of 31mg and mean hypotension duration of 28min, mean arterial 
pressure (MAP) decreased by 43%, from 78.3 to 44.4mm Hg as a result of 
decrease in cardiac index (CI) 18% and systemic vascular resistance(SVR) 
21%. Simultaneously a moderate increase in (CaO2 – CvO2) 21% and a 
significant increase in plasma renin activity (90%) were observed. In patients 
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“sensitive” to NTG, the MAP decreased by 54%, CI by 27% and SVR by 
35%; HR remained stable. In patients resistant to NTG, the decreases in CI 
and SVR were less marked: 2% and 22% respectively; observed increase in 
HR was 12%. When nontoxic dosage of SNP were used (less than 
2micrograms/kg/min), hypotension was caused by decreased SVR (31%) and 
increased CI (8%). NTG alone can be used to produce controlled decreases in 
MAP to around 50mm Hg, and in patients “resistant” to NTG, SNP can be 
added to increase the hypotensive effect. 
 Mac Rac WR 1985
31
 the use of induced hypotension in the hands of a 
competent anaesthetist combined with the careful technique of a surgeon 
skilled in operating under these conditions can aid surgical access, improve 
delineation of pathology and reduce levels of blood loss, all of which are to 
the advantage of the patient. These advantages should encourage surgical and 
anaesthetic teams to become accomplished exponents of the art. 
 Gourdeau M et al 1986
19
 oscillometry using an automatic monitor 
was compared with invasive blood pressure monitoring in 21 patients 
scheduled for surgery under general anaesthesia with deliberate hypotension. 
Six ranges of mean blood pressure measurements were studied, two of which 
were hypotensive. An excellent correlation was found between the two 
methods (systolic: r=0.94; mean: r=0.93; diastolic: r=0.88) but there was a 
large variability among individual subjects. For systolic, diastolic and mean 
intra-arterial readings above an approximate value of 10.64 KPa (80mmHg), 
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the oscillatory monitor was found to underestimate blood pressure. Inversely, 
it was found to overestimate blood pressure for intra-arterial readings under 
the approximate value of 10.8 KPa (80mmHg). We conclude that the non-
invasive monitor represents a good trend estimation of the invasive radial 
blood pressure technique, but that wide inter-individual variability and the 
overestimation of blood pressure below an approximate value of 10.64 KPa 
(80mmHg) precludes interchange of techniques when absolute values are 
considered, especially during controlled hypotension. However, oscillometry 
could represent a better estimate of central aortic pressure. 
 Pasch T et al 1986
37
 over an eight year period (1977 – 1984), 1802 
otorhinolaryngological procedures were performed under controlled 
hypotension. Four patients showed symptoms of cerebral damage post-
operatively. One patient had pre-operative recognized stenosis of the internal 
carotid artery, another hypoplastic vertebral artery. In this female patient, the 
head had been strongly rotated to the side to expose the surgical field, and the 
internal jugular vein removed. She died of general ischaemic brain damage on 
the seventh post-operative day. In the remaining two patients, symptoms of 
cerebral ischaemia did not occur until the third and eleventh day, respectively, 
so that the causative role of hypotensive anaesthesia is uncertain. The cases 
described represent a cerebral morbidity of 4:1,802 (0.22%) and a mortality of 
1:1,802 (0.06%). It is concluded that controlled hypotension is a safe 
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technique if the induction is stringently applied, and any risk bearing factors 
are carefully excluded. 
 Campkin TV et al 1986
5
 the used isoflurane to induce arterial 
pressure (MAP) to the desired level for surgery; for the remainder, a higher 
concentration (3.0-4.0%) was required. Tachycardia, which could be slowed 
by labetalol, occurred in13 patients (32%); the incidence was significantly 
higher in those who had not received an opiod either as premedication or intra-
operatively. No post-operative complications attributable to hypotension were 
seen. It is concluded that isoflurane is a safe and effective agent for the 
induction of hypotension in neurosurgical operations. 
 Myron Yaster MD et al 1986
33
 compared nitroglycerine and 
nitroprusside for inducing hypotension in children by conducting a double 
blind study. NTG is doses as high as 40 mg/kg
-1
min
-1
 was in effective at 
decreasing mean arterial pressure below 55mm Hg or causing a decrease in 
MAP greater than 1/3
rd
 of base line values. SNP was uniformly successful at 
inducing hypotension in all patients; including those patients in than NTG 
failed. NTG & SNP decreased systemic vascular resistance, although SNP did 
so to a much greater degree. Both drug reflexly increased heart rate, 
necessitating the use of propanol, and decreased arterial oxygen tension to a 
small extent. SNP appears to be the agent of choice for the reliable and 
sustained induction of deliberate hypotension in children and adolescents. 
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 Sollevi A 1988
47
 Controlled hypotension reduces blood loss during 
defined major surgical procedures, which in turn will minimize transfusion 
needs and thereby the risks of transmission of infectious diseases. There is no 
evidence that hypotension below 8 kPa (60 mmHg) (MAP) is associated with 
better blood sparing effects that a more moderate hypotension, but it will 
probably increase the risk of cardiovascular complications. Therefore, 
controlled hypotension, being a sophisticated technique, requires handling by 
an experienced anaesthetist well aware of contraindications and the need for 
adequate monitoring for prevention of tissue ischemia. Large randomized and 
prospective studies are still warranted, especially for further evaluation of the 
risk-benefit with controlled hypotension. 
 Lessard MR et al 1989
30
 studies the effect of isoflurane induced 
hypotension on reduction of blood loss, improvement of surgical field, and 
postoperative oedema in 52 patients undergoing combined maxillary and 
mandibular osteotomies. Blood loss in the hypotensive group (MAP – 55 to 65 
mmHg) was significantly less than that in the control group (MAP – 75to 85 
mm Hg); 454 +/- 211.3 ml Vs 755.3 +/- 334.6 ml (fewer patients had to be 
transfused in the hypotensive group 12% Vs 44%). The surgical field 
improved significantly, but operative time was not shortened. Subjective and 
objective measurements of postoperative oedema failed to show any effect of 
deliberate hypotension. They concluded that enflurane-induced hypotension 
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effectively reduces blood loss and the number of transfusion in orthognathic 
surgery. 
 J. E. Moening et al 1995
34
 did a retrospective study comparing 506 
patients who underwent orthognathic surgery both single and double jaw. 
Average estimated blood loss for all groups was 273.23 ml. Double jaw 
surgery resulted in more blood loss than single jaw procedure. Men and boys 
bleed more than women and girls. Only 0.8% received blood transfusion. They 
concluded that for reducing blood loss are hypotensive anaesthesia, single 
surgical team and constant surgical setting. 
 Precious DS et al 1996
39
 had compared blood loss, quality of surgical 
field, and duration of procedure in normotensive and hypotensive anaesthesia 
in adolescent orthognathic surgery patients. Sample size was 25 in each group. 
Results showed significant decrease in blood loss, better surgical field with no 
significant difference in duration of the procedure with induced hypotensive 
anaesthesia. 
 Nabil Samman et al 1996
35
 quantified the blood loss & transfusion 
requirements in orthognathic surgery by a retrospective study, comprising 360 
healthy orthognathic surgery patients. Estimated blood loss ranged from 50 to 
5000 ml, 24% were transfused. 8.7% - single jaw surgery and iliac bone 
harvest 26.7% after bimaxillary surgery. 
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 Guyron B et al 1996
21
 Desmopressin (1 – deamino-8-D-
argininevasopressin, DDAVP) is a synthetic analog of the antidiuretic 
hormone L – argininevasopressin. DDVAP has been shown to increase the 
plasma concentration of endothelial factor VIII, thus increasing coagulant 
activity. There is evidence from controlled clinical trials indicating that 
DDVAP can reduce blood loss and transfusion requirements for individuals 
with normal coagulation profiles undergoing various surgical procedures. This 
study was conducted to evaluate the efficacy of the DDVAP in reduction of 
blood loss during orthognathic surgery. 20 patients, 15 females and 5 males, 
undergoing bimaxillary osteotomy were randomized into two groups of ten. 
Perioperatively, group 1 patients received 20 micrograms of DDVAP infused 
over one-half hour. Group II patients did not receive DDVAP. Hypotensive 
anaesthesia (mean arterial pressure < 60 mmHg) was routinely employed for 
both groups. On average, the blood loss in group 1 patients was 144 ml less 
per patient than group II patients (p < 0.50). Only 2 of 10 patients in group 1 
lost in excess of 750 ml (p < 0.20). The average postoperative haematocrit for 
patients in group 1 dropped by 6.17 of the preoperative mean haematocrit                    
(p < 0.001). The average drop in haematocrit among the group II patients was 
11.61 (p < 0.001). When collated this haematocrit drop of 11.61 for group II 
and 6.17 for group I (recipients of DDVAP) proved to be significantly 
different (p < 0.01). It is concluded from this study that patients receiving a 
standard dose of DDVAP prior to bimaxillary osteotomy would experience 
reduced intraoperative blood loss, providing that blood pressure is well 
Review of Literature 
 
22 
 
 
controlled and fluid replacement is carefully managed. No significant adverse 
side effects of desmopressin acetate were observed.   
 Van de Perre JP et al 1996
51
 the data of 2049 patients, who 
underwent maxillofacial orthopaedic surgery, were retrospectively analysed 
for major intra- and immediate postoperative complications. Immediate life-
threatening complications were very rare. They can in most cases be avoided 
by good anaesthetic and surgical techniques and adequate postoperative care. 
The most frequently encountered problem in maxillary surgery is excessive 
blood loss, whilst a compromised airway due to swelling is the most frequent 
complication in mandibular surgery. Good co-operation between anaesthetist 
and surgeon is essential to prevent major intraoperative and immediate 
postoperative problems. 
 Enlund MG et al 1997
12
 the need for induced hypotension in 
orthognathic surgery was evaluated. Blood loss, duration of operation, quality 
of the surgical field, and surgical result were measured in 36 patients, assigned 
to either hypotension (mean arterial pressure, MAP, 50-64 mmHg) or 
normotension (MAP > or = 65 mmHg).  Hypotension was achieved by 
increasing the amount of isoflurane given. The hypotensive group had 
significantly less bleeding over time (mean 0.9 ml/minute, 95% confidence 
interval (Cl) of mean 0.6 to 1.2, compared with 1.8, 95% Cl 1.3 to 2.4,                      
p = 0.005). The corresponding difference in total blood loss did not differ 
significantly between groups (mean 186 ml, 95% Cl 98 to 275, compared with 
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304ml, 95% Cl 210 to 399). No patient required transfusion of red cells. 
Neither the duration of surgery, nor the quality of the surgical field, or the 
final results were significantly influenced by hypotension. The clinical 
relevance of induced in orthognathic surgery must be considered to be 
doubtful. A mean reduction of less than 150 ml will be of limited value at the 
low levels of blood loss reported. 
 R.G. Rohling et al 1999
42
 have described a protocol of blood-saving 
measures, which was rested on a sample of 127 patients treated between 1994 
& 1997. The protocol comprises acute normovolemic haemodilution, 
controlled moderate hypotension, positioning the surgical field above the heart 
level, cell saving, intra operative homeostasis, preoperative autologous blood 
donation, administration of recombinant erythropoietin, and acceptance of low 
haematocrit perioperatively. This study showed that homologous blood 
transfusion might be awarded intra operatively by following the protocol. 
 CNF Yu et al 2000
7
 in their prospective study including 32 patients 
undergoing orthognathic surgery under induced hypotensive anaesthesia found 
that mean estimated blood loss for double jaw surgery was 617.6ml mean EBL 
during Lefort I was half that of multiple segmentalised osteotomies for 
mandibular ramus osteotomies, mean BBL and operating times was 280 ml 
and 2 hours respectively, for anterior mandibular osteotomies the 
corresponding values were 171.3 ml and 1 hour 13 minutes. Average drop in 
haematocrit value was 15.4%. A bivariate correlation test between the blood 
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loss and operating time are a strong correlation (p<0.01) as did blood loss with 
a drop in haematocrit value (p<0.01). Orthognathic surgeries are thus safe and 
predictable in terms of intra operative blood loss and operating time. 
 Ekback G et al 2000
11
 Intraoperatively administered, tranexamic acid 
(TA) does not reduce bleeding in total hip replacement (THR). Therefore, its 
prophylactic use was attempted in the present study because this has been 
shown to be more effective in cardiac surgery. We investigated 40 patients 
undergoing THR in a prospective, randomized, double-blinded study. Twenty 
patients received TA given in two bolus doses of 10 mg/kg each, the first just 
before surgical incision and the second 3 h later. In addition, a continuous 
infusion of TA, 1.0 mg. kg (-1) for 10 h, was given after the first bolus dose. 
The remaining 20 patients formed a control group. Both groups used 
preoperative autologous blood donation and intraoperative autotransfusion. 
Intraoperative bleeding was significantly less (P = 0.001) in the TA group 
compared with the control group (630 +/- 220 mL vs 850 +/- 260 mL). 
Postoperative drainage bleeding was correspondingly less (P = 0.001) (520 +/- 
280 vs 920 +/- 410 mL). Up to 10 h postoperatively, plasma D-dimer 
concentration was halved in the TA group compared with the control group. 
One patient in each group had an ultrasound-verified late deep vein 
thrombosis. In conclusion, we found TA, administered before surgical 
incision, to be efficient in reducing bleeding during THR. Implications: In a 
prospective, double-blinded study of 40 patients undergoing total hip 
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replacement, the preoperative administration of tranexamic acid reduced 
bleeding by 35%, probably by decreasing induced fibrinolysis. Whether 
tranexamic acid therapy can replace predonation of autologous blood or 
intraoperative autotransfusion requires further study. 
 Dolman RM et al 2000
41
 conducted a prospective study to compare 
the quality of the surgical field, blood loss, and operating time with either 
hypotensive or normotensive anaesthesia during Lefort I osteotomies. 23 
patients were randomised into normotensive or hypotensive anaesthesia 
groups. The quality of the surgical field was assessed intra operatively by 
direct observation and again postoperatively by video imaging. There was a 
statistically significant correlation (p < .0001) between the surgeon’s 
perception of the quality of the surgical field and the blood pressure. There 
was also statistically significant reduction (p < .01) in blood loss when using 
hypotensive anaesthesia and there was no statistically significant reduction (p 
= 0.44) in operating time when using hypotensive anaesthesia. 
 Praveen K et al 2001
38
 conducted a randomized study to find out 
whether hypotensive anaesthesia minimized blood loss during orthognathic 
surgery. 53 consecutive patients, 15-33 years old were randomly allocated to 
either normotensive or hypotensive anaesthesia. Patients under hypotensive 
anaesthesia showed a Median (range) blood loss/operation (ml) was 200 (90-
400) ml and under normotensive anaesthesia were 350ml (130- 1575)                     
(p = 0.01), and those for maxillary segmental osteotomy under hypotensive 
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anaesthesia were 85 (40-240) ml and under normotensive anaesthesia were 
175 (100-190) ml (p = 0.05). Result showed that there was pronounced 
reduction in blood loss during orthognathic surgery done under hypotensive 
anaesthesia.  
 Stewart A et al 2001
48
 have done randomized, placebo controlled, 
double blind trial (each 15), giving Apotronin intravenously (200ml) before 
the operation and then 50 ml per hour until the end of the operation during 
simultaneous Lefort I and mandibular sagittal split osteotomies, lost 52% less 
blood than control. EBL in apotronin group was 473 ml compared with 986 ml 
in controls. Blood was transfused in 1 patient in apotronin group compared to 
9 in control group. No complications due to drug encountered. 
 Goran Zellin et al 2004
18
 determined whether the addition of 
haemorrhage depressors to other medication during orthognathic surgery 
would further reduce the blood loss. Thirty patients undergoing Lefort I 
osteotomy were studied, one group was operated under hypotension 
anaesthesia, the other under received additional haemorrhage depressors, 
tranexamic acid and desmopressin. The results showed statistically significant 
reduction of blood loss in the treatment group (P < 0.01). They concluded that 
blood loss during orthognathic surgery under hypotensive anaesthesia could be 
significantly reduced when a combination of tanexamic acid and desmopressin 
is added. 
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 D. K. Dhariwal et al 2004
8
 reviewed the records of 115 consecutive 
cases of simultaneous bimaxillary osteotomies at Morriston Hospital over a 5 
year period and they concluded that for patients requiring bimaxillary 
orthognathic surgery, it was important to evaluate each patient for their cross-
matching requirements. 
 Emeka Nkenke et al 2005
13
 did a clinical study to assess the reduction 
of the haemoglobin value and the frequency of blood transfusions during 
bimaxillary orthognathic surgery in 56 patients and concluded that the 
haemoglobin value reduced postoperatively by 2.6 +/- 1.4 g/100ml in the non-
donors and by 2.6 +/- 1.1 g/100ml in the donors need blood transfusion 
 Koichiro Ueki et al 2005
27
 did a study in 62 prognathic patients to 
predict the need for blood transfusion during orthognathic surgery and he 
concluded that the transfusion was not necessary in IVRO (intra oral vertical 
ramus Osteotomy) or SSRO (sagittal split Osteotomy) with or without Le Fort 
I Osteotomy. 
 Peter Kessler et al 2006 did a study to determine the frequency of 
blood transfusion and to evaluate the need for autogenous blood donations in 
patients undergoing bimaxillary orthognathic surgery and concluded that the 
preoperative autogenous blood transfusion appears to be effective in reducing 
exposure to allogenic blood. 
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 W.S. Choi et al 2008
4
 did a systematic review to investigate the 
evidence of the risks like increased heart rate, decrease in systemic vascular 
resistance, decrease in arterial oxygen tension, reduced urine flow which can 
be reversed to normal and benefits like decreased blood loss, increased 
surgical visibility, decrease surgical time. Finally author concluded although 
there are certain risks associated with hypotensive anaesthesia, most 
orthognathic patients are young and fit and complications are rare which can 
be avoided by thorough preoperative assessment and appropriate continuous 
monitoring. 
 Yoshikawa. F et al 2009
54
 conducted a study to determine the 
difference in endocrine response, blood loss and arterial blood gas profiles 
between patients subjected to hypotensive anaesthesia or normotensive 
anaesthesia in 36 patients and concluded that blood loss was smaller and 
duration of surgery was shorter in hypotensive anaesthesia group and no 
significant differences in hormone levels in either group 
 Alissa Lockwood et al 2010
1
 did a critical review of the evidence and 
clinical relevance to confirm the associated cyanide toxicity in adult patients 
with sodium nitroprusside and concluded that SNP is still a reasonable agent 
to use in the management of patients with hypertension today and can safely 
be used beyond doses of 2 µg/kg/min. Furthermore, in lieu of CN levels, 
monitoring of lactic acid levels is also reasonable measure to ensure safety. 
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 J.Ervens et al 2010
10
 did a prospective, single blinded, randomized 
controlled clinical study to compare the effect of induced hypotensive 
anaesthesia vs isovolaemic hemodilution on blood loss and transfusion 
requirements in orthognathic surgery and concluded that the hypotensive 
anaesthesia significantly reduces blood loss and transfusion risks whereas 
induced hypotensive anaesthesia combined with isovolaemic hemodilution has 
no addition blood sparing effects but impairs surgical field quality. 
International journal of oral and maxillofacial surgery in 2010. 
 Varol .A et al 2010
53
 conducted a study to evaluate the role of induced 
hypotension during maxillary downfracture osteotomy on the requirement for 
blood transfusion, duration of operation in bimaxillary surgery in 45 young 
patients. Concluded that none of the patients received a blood transfusion and 
transfusion in bimaxillary orthognathic surgery could be prevented by 
induction of hypotension during maxillary downfracture. 
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MATERIALS AND METHODS 
Patients: 
            This study is conducted at department of Oral and Maxillofacial 
Surgery, Ragas Dental College and Hospital, Chennai.  A total of 10 cases                
(5 males and 5 females, the mean age was 22.9 years, with an age range of 18-
27 years) undergoing Orthognathic Surgery were included in this clinical 
study. These patients underwent Orthognathic Surgeries from July 2011 to 
October 2012. Informed Consent was obtained from the Patient, 
Parents/Guardian and Institutional Ethical Committee. 
                Data included age, sex, patient’s complaint, relevant medical history 
and dental history, clinical findings, blood investigations, radiographic 
findings, cephalometric findings including Preoperative and Postoperative 
blood loss during surgery and the duration of surgery was calculated. 
             All patients were fit, young and healthy adults (ASAPS 1). General 
examination was carried on and medical status was evaluated. All patients 
denied usage of any medication within the 2 weeks prior to surgery. None of 
the patients had known connective tissue disorder, Cardiovascular, renal, 
respiratory and hepatic disorder, h/o haemostatic disorder or diasthesis were 
excluded. Diagnosis was made from clinical, radiographic and cephalometric 
findings. 
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           Treatment was planned giving patient’s concerns prime importance, 
surgeries included Anterior Maxillary osteotomies (n=6), Lefort 1 osteotomies 
(n=1), BSSRO (n=3), Subapical Osteotomies (n=1), Genioplasty (n=3) 
.Patients were given Hypotension Anaesthesia intra-operatively.                           
Pre-operatively Blood Pressure, Pulse rate, Haemoglobin and Hematocrit was 
calculated, duration of the surgery was calculated. 
Method: 
Patient Preparation: 
 Patients were prepared the day prior to the procedure, 2ml of blood 
withdrawn from Brachial Vein and cross matching done in VHS blood bank, 
one unit of whole blood booked for the surgery. All patients were Nil-by-
mouth from 6 hours prior to the surgery.  
Pre-Medication: 
            Pre-medication comprised Inj. Fortwyn 0.6 mg/kg, Inj. Phenergan 0.5 
mg/kg, Inj. Glycopyrolate 0.04 mg/kg, which was given intra-muscular 30 min 
prior to surgery.  
 Induction anaesthesia was induced by Inj. Thiopentone 5mg/kg and 
Inj. Succinyl Choline 1-2 mg/kg Intra-venously. Patients were intubated by 
cuffed nasoendotracheal tube. Anaesthesia was maintained by N2O and O2 
(60:40 ratio) and long acting muscle relaxants Inj. Vercuronium bromide 0.08 
mg/kg. Throat pack was placed using ribbon gauge of standard length. 
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               Local anaesthesia was given using 2% lignocaine with 1:2,00,000 
adrenaline. Before making incision in all cases head end was elevated.   
Electrocautery was used in all surgeries for incision. Patients were given 
Nitroglycerine (3-10 mcg/kg/min) as induced hypotensive anaesthesia diluted 
in DNS or 5% Dextrose before the osteotomy cut was performed. Mean 
arterial pressure was maintained around 70 mm/Hg till the osteotomy 
fragments were fixed. Inj. Taxim 1gm, Inj. Metrogyl 500mg, Inj. Decadron 
8mg, Inj. Rantac 50mg , Inj. Emeset 4 mg given IV during  the surgery and Inj 
Voveron 3cc given IM post operatively, nitroglycerine was slowly reduced as 
Mean arterial pressure slowly raised .Anaesthesia was withdrawn by giving 
reversal using Inj. Neostigmine+Glycopyrolate 0.05-0.07 mg/kg.    
Haemostasis was checked. None of the patients were placed with haemostatic 
agent like surgical or bone wax.   
             Intra-operative monitoring comprised Electrocardiography, Blood 
pressure, Pulse oximetry and Heart rate. Continuous monitoring of Blood 
pressure was done by non-invasive method (oscillometry). (MAP = diastolic 
pressure+1/3 of pulse pressure).    
 Anaesthesia duration time was calculated from induction to reversal 
and surgery duration from incision to last suture. 
             A single observer measured blood loss after every surgery. It was 
measured by reducing the amount of saline used, from the volume of fluid in 
suction unit, weight of dry gauze was deducted from weight of the blood 
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soaked gauze. 1 gm of weight was considered 1 ml of blood. The need to 
transfuse blood post operatively was decided by the Anaesthetist.   
Statistical procedures   
The data obtained was tabulated meaningfully in Microsoft Excel 
spread sheet and subjected to statistical analysis. Data analysis was carried out 
using SPSS version 19. Data related to Arterial pressure, Blood loss and 
Duration of surgery was expressed in terms of descriptive statistics. 
Comparison between the means of Haemoglobin%, Haematocrit% and RBC% 
among study subjects before and after surgery was done using Paired t test. 
For all the analysis p value of < 0.05 was considered to be statistically 
significant.  
Estimation of Estimated Blood Volume (EBV) and Allowable Blood Loss 
(ABL): 
ESTIMATED BLOOD VOLUME: 
 Neonates – 85 -90 ml/kg body weight 
 Children – 80 ml/kg body weight 
 Adults – 70 ml/kg body weight 
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ALLOWABLE BLOOD LOSS: 
 
METHOD 
 
HEALTHY 
AVERAGE 
CLINICAL 
CONDITION 
POOR CLINICAL 
CONDITION 
PERCENTAGE 
METHOD  
(ACCEPTABLE  
LOSS OF 
 BLOOD VOLUME) 
30% 20% LESS THAN 10% 
 
                   EBV  x (PREOPERATIVE Hb – LOWEST ACCEPTABLE Hb) 
ABL=           
              (AVERAGE OF PREOPERATIVE & LOWEST ACCEPTABLE Hb) 
 
Data collection: 
               Gauze of standard size was used. Weight of the gauze was 
determined before sterilizing. Volume of the saline used for irrigation was 
recorded. Volume of fluid (saline + blood) in suction was noted. Weight of the 
blood soaked gauze was determined. These data were collected using 
Gravimetric and Volumetric method. 
BLOOD LOSS = (A+B) 
A = Volume in suction – Volume of saline used 
B = Weight of wet gauze – Weight of dry gauze 
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                                                PROFORMA 
MEASURMENT OF BLOOD LOSS – IN SURGICAL PROCEDURE 
NAME:                                                         OP NO: 
AGE: 
SEX: 
WEIGHT: 
PAST MEDICAL HISTORY 
RESPIRATORY: 
CVS: 
RENAL: 
HEPATIC: 
 
DIAGNOSIS: 
 
SURGERY PLANNED: 
 
DATE OF SURGERY: 
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PREMEDICATION: 
 
 Pre-operative Post-operative 
Blood Pressure   
Hb%   
Hct   
 
INTRA OPERATIVE MONITERING 
Time    BP   
Systolic 
    BP 
Diastolic 
Mean Heart rate PO2% 
      
      
      
      
      
 
ANAESTHESIA:      START-                         FINISH- 
 SURGERY :            START-                         FINISH- 
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BLOOD LOSS: 
VOLUME OF SALINE USED 
 INTRA OPERATIVELY 
 
VOLUME OF FLUID IN SUCTION 
APPARATUS 
 
WEIGHT OF GAUZE SOAKED IN BLOOD  
WEIGHT OF DRY GAUZE  
TOTAL BLOOD LOSS  
 
  Figures 
 
 
 
Fig 1 : PULSEOXIMETER 
 
 
Fig 2 : NITROGLYCERINE DILUTED IN DNS 
 
 
  Figures 
 
 
 
Fig 3 : WEIGHING MACHINE WITH BLOOD SOAKED GAUZE 
 
Fig 4: SUCTION DRAIN 
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HISTORY 
  Controlled moderate hypotensive anaesthesia is beneficial in 
providing a clear surgical field and avoids the necessity of blood transfusion 
and its inherent risks.  
 Anaesthesia became easy and satisfactory for the anaesthetist when 
cyclopropane was used, but it was a troublesome for the surgeon due to excess 
bleeding. The side effect of cyclopropane was skin showing marked 
vasodilatation.  
 Deliberate hypotension was first proposed by Harvey Cushing in 1917 
for neurosurgery. Induced hypotension was first given by Gardener
24
 in 1946 
as a separate anaesthetic procedure. 
 In 1948, Griffiths and Gillies reported high spinal anaesthesia, 
blocking sympathetic fibres, which induced vasodilatation below the level of 
block and produced profound hypotension. 
 Enderby used Pentamethonium iodine as the first hypotensive agent to 
reduce blood loss. Magill in 1953 successfully used short acting ganglion 
blocker trimethaphan, which had better control over blood pressure. Other 
ganglionic blockers that followed soon were hexamethonium, pentolinium, 
guanethidine. 
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 Lessard in 1989 had used isoflurane successfully in combined jaw 
surgeries.
30
 PG E1, adenosine, calcium channel blockers are recently 
introduced hypotensive agents.  
 Schaberg
44
 has evaluated effects on sodium nitroprusside infusion 
supplemented with halothane in oral- facial corrective surgery. 
 Kerr
26
 produced a blood free field for middle ear surgery done with an 
operating microscope by means of thiopentone – halothane-nitrous oxide 
together with pentolinium tartrate. Sivarajan
46
 used trimethaphan infusion 
which decreased cardiac output characteristically. 
 Bergman
3
 in 1982 was the first to used enflurane, sodium nitroprusside 
(SNP) and nitroglycerine (NTG) on oral tissues and determined NTG and SNP 
produced significant reduction in blood flow. Golia and Guggiari used 
nitroglycerine for controlled hypotension in orthognathic surgery.
17,20
 Yaster 
M
33
 in 1986 did a comparative study on nitroglycerine and nitroprusside. 
Fahmy
14 
substituted enflurane for halothane to induce controlled 
hypotension, along with B-blockers and sympathetic ganglionic blockers. 
Lam
28
 used isoflurane to induce deliberate hypotension in 1983.  
 Campkin used isoflurane to induce arterial pressure (MAP) to the 
desired level for surgery.
5 
Guyron
21
 used Desmopressin a synthetic analog of 
the antidiuretic hormone L-argininevasopressin for reducing blood loss and 
transfusion.  
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Ekback
11 
reported intraoperative administration of tranexamic acid 
(TA) doesnot reduce bleeding in total hip surgery. Samman
4
 in 2008 did a 
study in risk and benefits of deliberate hypotension using nitroglycerine. 
Praveen K et al
38
 in 2001 used nitroglycerin and esmolal as hypotensive agent 
in orthognathic surgery.   
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PHARMACOKINETICS AND PHARMACODYNAMICS  
 NITROGLYCERINE: 
 The drug has been used for years to treat patients coronary artery 
spasm or with myocardial infractions and to control periods of hypertension 
in-patients with known coronary artery disease. Chemical name of 
nitroglycerine is 1,2,3 propanetriol nitrate. The chemical structure of 
nitroglycerine is, 
H2C – O – NO2  
HC – O – NO2 
Properties: 
 Nitroglycerine is basically a vascular smooth, muscular relaxant. It 
dilates both arterial and venous beds; however, it has preferential effect on the 
post capillary vessels, including large veins to which it promotes peripheral 
pooling of blood and decreasing venous return to the heart leading to the 
reduction to left ventricular and diastolic volume (pre-load). Arterial 
relaxation produced by nitroglycerine leads to reduction in systematic vascular 
resistance and arterial pressure (after-load). These effects of nitroglycerine 
produce reduction in the myocardial oxygen consumption or demand and thus 
a more favourable supply – demand and thus a more favourable supply –
demand ratio is achieved. The recommended doses of intra venous 
nitroglycerine reduce systolic, diastolic and mean arterial pressure while 
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maintaining effective coronary perfusion pressure, unless there is an excessive 
pain in blood pressure. 
 Intra venous nitroglycerine therapy reduces elevated central venous 
and pulmonory capillary wedge pressures, pulmonary vascular resistance and 
systemic vascular resistance. Heart rate is usually slightly increased, as a part 
of the reflex response to the fall in blood pressure. Cardiac index may be 
increased, decreased or unchanged. In the presence of elevated left ventricular 
filling pressure and systemic vascular resistance along with the depressed 
cardiac index there is a likelihood of an improvement in cardiac index. On the 
other hand, when filling pressures and cardiac index is normal, cardiac index 
may be slightly reduced by intra venous nitroglycerine therapy. 
PHARMACOKINETICS: 
 Nitroglycrine is widely distributed in the body and is rapidly 
metabolized to dinitrates and mononitrates. It has a short half-life, estimated of 
2 -8 minutes. This make it possible to monitor and control the plasma levels of 
nitroglycerine during intra venous infusion.  
 Nitroglycerine is readily absorbed into the plastic materials parenteral 
solution containers and tubings of intra venous infusion sets. Therefore, the 
dilution and storage of nitroglycerine for intra venous infusion should be made 
only in glass parenteral solution bottles. 
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 Forty percent to eighty percent of the total amount of nitroglycerine in 
the final diluted solution for infusion is absorbed by the polyvinyl chloride 
(PVC) tubing of the intra venous administration sets. The rate of absorption 
depends upon the flow rate, nitroglycerine concentration and the length of the 
tubing etc… 
INDICATIONS: 
1. Angina pectoris, including unstable angina pectoris and post-
infraction angina pectoris in patients who have responded to 
recommended doses of organic nitrates and or beta blockers. 
2. Acute myocardial infraction, congestion heart failure and 
improvement of coronary circulation opening of collaterals and 
reduction of infract size. 
3. Control of blood pressure in perioperative hypertension i.e., 
hypertension associated with surgical procedures, especially 
cardiovascular procedures, such as hypertension seen during 
intratracheal intubation, anaesthesia; skin incision, osteotomy, 
cardiac bypass and in the immediate postsurgical period. 
4. Production of controlled hypotension during orthognathic 
procedures. 
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CONTRAINDICATIONS: 
1. Known hypersensitivity to nitroglycerine or other organic 
nitrates. 
2. Hypotension or uncovered hypovolaemia as the use of 
nitroglycerine injection in such conditions could produce 
severe hypotension or shock. 
3. Increased intracranial pressure (eg: head trauma or cerebral 
haemorrage). 
4. Inadequate cerebral circulation, constrictive pericarditis and 
cardiac tamponade.  
PRECAUTIONS: 
1. Nitroglycerine injection should be used with caution in 
patients with severe hepatic or renal disease. 
2. Excessive fall in blood pressure, especially for prolonged 
periods of time, must be avoided because of possible 
deleterious effects on the brain, heart, liver and kidney from 
poor perfusion and the attendant risks of ischemia, thrombosis 
and altered functions of these organs. Patients with normal or 
low pulmonary capillary wedge pressure are especially 
sensitive to the hypotensive effects of nitroglycerine injection. 
It is advisable to monitor the pulmonary capillary wedge 
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pressure to titrate the dosage of the drug and as it generally 
proceeds the occurrence of arterial hypotension. 
3. Use during pregnancy: The safety of the use of nitroglycerine 
injection during pregnancy has not been established; therefore 
it should be given to pregnant women only if clearly needed. 
ADVERSE EFFECTS:  
 The commonly observed adverse effects of nitroglycerine injection are 
extensions of its pharmacological actions, which include headache, flushing, 
dizziness. Nausea, vomiting and abdominal pain have also been reported. 
Paradoxical bradycardia and increased angina pectoris may accompany 
nitroglycerine induced hypotension. 
DOSAGE AND ADMINISTRATION: 
 Nitroglycerine injection is a concentrated, potent drug, which must be 
diluted in 5% dextrose or normal saline prior to infusion. It should not be 
admixed with other drugs. 
 The administration of nitroglycerine infusion is initially begin with 5 
microgram per minute with subsequent titration to adjust that dose in 
accordance with the clinical situations with increments of 5 microgram per 
minute, every 3 to 5 minutes until some response is noted. If no response is 
seen at 20 microgram per minute, increments of 10 and later 20 microgram per 
minute can be used. Once a partial blood pressure response is observed, the 
dose increase should be reduced and the interval between increments should 
be lengthened. 
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RESULTS 
 The study was conducted in 10 young healthy individual undergoing 
orthognathic procedures. The male: female ratio was 1:1 (five males and five 
females), with an age range of 18 – 27 years (mean – 22.9 years). All 10 
patients were subjected to Hypotensive anaesthesia. The Mean Arterial 
Pressure (MAP) ranges from 63.30 mmHg – 78.60 mmHg (Mean – 72.86 
mmHg). 
DURATION OF SURGERY: 
            The total operating time consists of time taken from start of surgery, 
administration of Local anaesthesia, extraction of tooth, mucoperiosteal 
incision, osteotomy cut and downfracture, control of bleeding, fixation and 
closure of last suture. The operating time for maxillary single jaw surgery 
ranges from 100 – 160 min (Mean – 65.20 min), mandibular single Jaw 
surgery ranges from 75 – 270 min (Mean – 160 min), Bi-jaw surgery ranges 
from 140 – 290 min (Mean – 236.6 min). The total operating time in this study 
ranges from 75 – 290 min (Mean – 174 min). 
BLOOD LOSS:  
              The amount of blood loss was calculated by reducing the amount of 
suction collection with the amount of saline used for irrigation and by 
weighing the already weighed blood soaked gauze and throat pack. Each gram 
increase in wet gauze will denote I ml blood. By adding these two variables 
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total blood loss was calculated in this study.  Blood loss in maxillary single 
jaw surgery was 158.4 min – 174.2ml (mean – 169.6 ml), mandibular single 
jaw procedure was 77.60 ml – 169.6 ml (mean – 117.7 ml) and in bi-jaw 
procedure was 200 ml – 283 ml (mean – 236.76 ml). The total blood loss 
ranges from 77.60 ml – 283 ml (mean – 174.19 ml). There was a minimal 
amount of blood loss noted.  
Preoperative/Postoperative Hg, Hct and RBC levels: 
              Pre and Post-op Haemoglobin, Haematocrit and RBC values were 
calculated. The mean Haemoglobin% pre and post-operatively was 12.14 % 
and 10.04% respectively. The mean Haematocrit% pre and post-op was 
40.50% and 33.20% and the mean RBC% value pre and post-op was 36.42% 
and 30.18%.  
DEMOGRAPHIC DATA 1: SHOWING PATIENTS AGE, SEX, 
WEIGHT & PER OPERATIVE MEAN ARTERIAL PRESSURE 
VARIABLES VALUES 
Sex: Male 
        Female 
5 
5 
Age (years) 22.9  
MAP  Preoperatively (mm Hg) 90.97 
Weight (Kgs) 54.1 
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DEMOGRAPHIC DATA 2: SHOWING PATIENTS PRE AND POST 
OPERATIVE HAEMOGLOBIN, HAEMATOCRIT, RBC 
Pt.no    Haemoglobin %        Haematocrit%            RBC% 
 Pre-op Post-op Pre-op Post-op Pre-op Post-op 
1 13.5 12.9 45 43 40.5 38.7 
2 9.0 6.7 30 22 27 20.1 
3 13.2 9.4 44 31 39.6 28.2 
4 11.8 10.4 40 34 35.4 31.2 
5 13.6 11.2 45 37 40.8 33.6 
6 12.9 9.8 43 32 38.7 29.4 
7 10.3 8.1 34 27 30.9 24.3 
8 11.4 10.2 38 34 34.2 30.6 
9 11.3 10.3 38 34 33.9 30.8 
10 14.4 11.6 48 38 43.2 34.8 
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DEMOGRAPHIC DATA 3: SHOWING THE TYPE OF SURGERY, 
BLOOD LOSS (ML), DURATION OF SURGERY (MIN) 
Pt.no Procedure Blood Loss (ml) 
Duration of 
surgery (min) 
1 Lefort I, BSSRO 283 280 
2 AMO 158.4 150 
3 BSSRO, Genioplasty 169.6 270 
4 Genioplasty 77.6 75 
5 AMO, BSSRO 227.3 290 
6 AMO 174 180 
7 AMO 171.8 160 
8 Genioplasty 106 95 
9 AMO, Subapical 200 140 
10 AMO 174.2 100 
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DEMOGRAPHIC DATA: 4 SHOWING THE MEAN ARTERIAL 
PRESSURE 
Pt.no Pre-op 
Before 
inducing NTG 
After inducing 
NTG 
Post-op 
1 86.6 98.3 76.6 90 
2 93.3 96.6 78.3 93.3 
3 93.3 88.3 78.6 96.6 
4 90 98.3 71.6 83.3 
5 93.3 96.6 63.3 93.3 
6 90 91.6 67.6 90 
7 93.3 90 73.3 93.3 
8 93.3 91.6 73.3 93.3 
9 83.3 83.3 70 80 
10 93.3 96.6 75.6 93.3 
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Table 1: Comparison of Haemoglobin%, Haematocrit% and RBC% 
among study subjects before and after surgery. 
*HS – Highly significant using Paired t test. 
Graph 1: Comparison of Haemoglobin%, Haematocrit% and RBC% 
among study subjects before and after surgery. 
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Pre-
operative 
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Pre-
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operative 
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Table 2: Blood loss and Duration of surgery among study subjects 
Variable N Range Minimum Maximum Mean 
(Median) 
Std. 
Deviation 
 Blood 
loss (ml) 
10 205.40 77.60 283.00 174.19 (172.9) 57.33 
Duration 
(minutes) 
10 215.00 75.00 290.00 174  
(155) 
79.85 
 
Graph 2: Mean Blood loss and Duration of surgery among study subjects 
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Table 3:  Mean Arterial pressure of the study subjects recorded at various 
time periods 
Time period  N Range Minimum 
(mm Hg) 
Maximum 
(mm Hg) 
Mean  
(mm 
Hg) 
Std. 
Deviation 
(mm Hg) 
Preoperative 10 10.00 83.30 93.30 90.97 3.53 
 
Before 
inducing 
NTG 
10 15.00 83.30 98.30 93.12 4.98 
After 
inducing 
NTG 
10 15.30 63.30 78.60 72.86 4.89 
one day post 
operative  
10 16.60 80.00 96.60 90.64 5.15 
 
Graph 3: Line diagram showing the mean arterial pressure of the study 
subjects recorded at various time period. 
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Graph 4: Scatter diagram showing the correlation between  the Amount 
of blood loss and Duration of surgery in minutes. 
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DISCUSSION 
 The result of this study indicated a reduction in intraoperative blood 
loss, clear and improved quality of surgical field but no statistically significant 
decrease in the operative time with the use of hypotensive anaesthesia. 
 In our studies the surgical procedures included maxillary osteotomy, 
segmental osteotomy or mandibular osteotomies under hypotensive 
anaesthesia, maintaining a mean arterial pressure of 72.86 mm Hg recorder 
with the use of non invasive blood pressure monitoring. 
 A standard 15
0
 elevation was practiced, patient in supine position on 
the operating table which was flexed and the angle of the mandible was above 
the level of the heart which influenced the blood loss. 
 Operating time could not be standardised due to variables like 
electrocautery setting, multiple surgeons, instrument handling during surgery, 
quality of surgical field and the length of the surgical procedure. 
 Nasal septal osteotomy, causing laceration of nasal mucosa resulted in 
increased bleeding, furthermore the transection of the descending palatine 
vessels resulted in the increased haemorrhage and operating time. 
 Blood loss was measured by volumetric and gravimetric techniques 
with strict attention directed to the amount of irrigation used. In our study 
nitroglycerin was used as hypotensive agent which maintained the mean 
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arterial pressure during osteotomy at 72.86 mm Hg. The mean operating time 
for single jaw surgery was 112.6 minutes, and 236.6 minutes for double jaw 
surgeries. 
 The mean blood loss for single jaw procedure was 143.65 ml and 
double jaw surgery was 236.76 ml on hypotensive anaesthesia. The operating 
time increased in the bi-jaw surgery which resulted as an increase in the blood 
loss in our patients. The mean body weight of our patients were 54.1 kgs.  
 The pre and postoperative blood investigations included Haemoglobin 
and Haematocrit values. The Mean preoperative haemoglobin was 12.14 gm% 
and the postoperative haemoglobin was 10.06 gm%, the difference in the 
mean haemoglobin between the pre op and post op values was calculated and 
the reduction in post op value was 2.08 gm%.  
 The Mean preoperative haematocrit was 40.50% and the mean 
postoperative haemoglobin was 33.20%, the difference in the mean 
Haematocrit between the pre and postoperative values was calculated and the 
reduction in post op value was 7.30%. No blood transfusion was required for 
any of our patients. The mean preoperative RBC value was 36.42% and mean 
postoperative value was 30.18%. The difference in the mean RBC between the 
pre and postoperative values was calculated and the reduction in post op value 
was 6.24% 
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 Controlled hypotensive anaesthesia in our study ranges from 63 – 78 
mmHg with mean of 72.86 mmHg which reduced the blood loss to minimum 
which are similar to studies conducted by Schaberg et al
44
 which reported 44% 
reduction in blood loss. 
 The advantages of controlled hypotensive anaesthesia are reduction in 
blood loss, improved visualization of surgical field, conservation of donor 
blood, increased speed and accuracy of surgery. 
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SUMMARY AND CONCLUSION 
 The use of hypotensive anaesthesia is a valuable tool in orthognathic 
surgery for the reduction of blood loss, improving the quality of surgical field, 
ease of surgery, controlling the length of surgery.  Hence, hypotensive 
anaesthesia is safe and routinely used in our institution for all orthognathic 
surgeries.  
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